Alternative molecular formats and therapeutic applications for bispecific antibodies

Spiess, Christoph, Zhai, Qianting, Carter, Paul J.·2015·Molecular Immunology

DOI 10.1016/j.molimm.2015.01.003

Cited by (607)

Items 101–200 of 607

Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18
Sílvia Carvalho, Francesca Levi‐Schaffer, Michael Sela, Yosef Yarden · 2016 · British Journal of Pharmacology
Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization
Guillaume Terral, Alain Beck, Sarah Cianférani · 2016 · Journal of Chromatography B
Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers
Roghaye Arezumand, Abbas Alibakhshi, Javad Ranjbari, Ali Ramazani, Serge Muyldermans · 2017 · Frontiers in Immunology
Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy
Minchuan Zhang, Kong‐Peng Lam, Shengli Xu · 2023 · Frontiers in Immunology
Computationally Designed Bispecific Antibodies using Negative State Repertoires
Andrew Leaver‐Fay, Karen Froning, S. Atwell, Hector Aldaz, Anna Pustilnik, Frances Lu, Flora Huang, Richard G. Yuan, Saleema Hassanali, Aaron K. Chamberlain et al. · 2016 · Structure
Augmenting adaptive immunity: progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires
Brown, Alex J., Snapkov, Igor, Akbar, Rahmad, Pavlović, Milena, Miho, Enkelejda, Sandve, Geir K., Greiff, Victor · 2019 · Molecular Systems Design & Engineering
A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity
Shiming Ye, Diane Dede Cohen, Nicole A. Belmar, Donghee Choi, Siu Sze Tan, Mien Sho, Yoshiko Akamatsu, Han Kim, Ramesh B. Iyer, Jean Cabel et al. · 2019 · Cancer Immunology Research
Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gap
Anthony Longhitano, Monica A. Slavin, Simon James Harrison, Benjamin W. Teh · 2021 · Blood Reviews
Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
Fabiola Vacca, Claudia Sala, Rino Rappuoli · 2022 · Biomedicines
Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6
Christiane Stadler, Hayat Bähr-Mahmud, Laura M. Plum, Kathrin Schmoldt, Anne C. Kölsch, Özlem Türeci, Uğur Şahin · 2015 · OncoImmunology
miRNA engineering of CHO cells facilitates production of difficult‐to‐express proteins and increases success in cell line development
Simon Fischer, Kim Fabiano Marquart, Lisa A. Pieper, Juergen Fieder, Martin Gamer, Ingo H. Gorr, Patrick Schulz, Harald Bradl · 2017 · Biotechnology and Bioengineering
Engineering bispecific antibodies with defined chain pairing
Simon Krah, Carolin Sellmann, Laura Rhiel, Christian J. Schröter, Stephan Dickgießer, Jan Beck, Stefan Zielonka, Lars Toleikis, Björn M Hock, Harald Kolmar et al. · 2017 · New Biotechnology
Coupling Mixed-Mode Size Exclusion Chromatography with Native Mass Spectrometry for Sensitive Detection and Quantitation of Homodimer Impurities in Bispecific IgG
Yuetian Yan, Tao Xing, Shunhai Wang, Thomas J. Daly, Ning Li · 2019 · Analytical Chemistry
Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats
Brent A. Williams, Arjun Law, Judit Hunyadkürti, Stéphanie Désilets, Jeffrey Victor Leyton, Armand Keating · 2019 · Journal of Clinical Medicine
High-throughput antibody screening from complex matrices using intact protein electrospray mass spectrometry
Sawyer, William S., Srikumar, Neha, Carver, Joseph, Chu, Phillip Y., Shen, Amy, Xu, Ankai, Williams, Ambrose J., Spiess, Christoph, Wu, Cong, Liu, Yichin et al. · 2020 · Proceedings of the National Academy of Sciences
A brief introduction of IgG-like bispecific antibody purification: Methods for removing product-related impurities
Yifeng Li · 2018 · Protein Expression and Purification
Debottlenecking protein secretion and reducing protein aggregation in the cellular host
Yizhou Zhou, Ravali Raju, Christina S. Alves, Alan Gilbert · 2018 · Current Opinion in Biotechnology
Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974
Hirotake Shiraiwa, Atsushi Narita, Mika Kamata‐Sakurai, Takahiro Ishiguro, Yuji Sano, Naoka Hironiwa, Takashi Tsushima, Hiroaki Segawa, Toshiaki Tsunenari, Yosuke Ikeda et al. · 2018 · Methods
Innovation in Chemistry, Manufacturing, and Controls—A Regulatory Perspective From Industry
Nina S. Cauchon, Shirley Oghamian, Soraya Hassanpour, Michael J. Abernathy · 2019 · Journal of Pharmaceutical Sciences
CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
Marta Włodarczyk, Beata Pyrzyńska · 2022 · Cancers
Bispecific antibodies in cancer immunotherapy
Siqi Chen, Jing Li, Qing Li, Zhong Wang · 2016 · Human Vaccines & Immunotherapeutics
Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies
Maxim Alekseevich Shevtsov, Gabriele Multhoff · 2016 · Frontiers in Immunology
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease
Robert J. Benschop, Chi-Kin Chow, Yu Tian, James Nelson, Barbra Barmettler, S. Atwell, David K. Clawson, Qing Chai, Bryan E. Jones, J.R. Fitchett et al. · 2019 · mAbs
Unraveling what makes a monoclonal antibody difficult‐to‐express: From intracellular accumulation to incomplete folding and degradation via ERAD
Sven Mathias, Anna Wippermann, Nadja Raab, Nikolas Zeh, René Handrick, Ingo H. Gorr, Patrick Schulz, Simon Fischer, Martin Gamer, Kerstin Otte · 2019 · Biotechnology and Bioengineering
Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies
Cholpon Tilegenova, Saeed Izadi, Jianping Yin, Christine Huang, Jiansheng Wu, Diego A. Ellerman, S.G. Hymowitz, Benjamin T. Walters, Cleo M. Salisbury, Paul J. Carter · 2019 · mAbs
Therapeutic bispecific antibody formats: a patent applications review (1994-2017)
Marie Godar, Hans de Haard, Christophe Blanchetot, Jacobus Rasser · 2018 · Expert Opinion on Therapeutic Patents
Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeys
Amita Datta‐Mannan, Johnny E. Croy, Linda Schirtzinger, Stacy Torgerson, Matthew Douglas Breyer, Victor J. Wroblewski · 2016 · mAbs
Antibody-Based Cancer Therapy
Djoke Hendriks, Goda Choi, Marco de Bruyn, Valerie R. Wiersma, Edwin Bremer · 2017 · International review of cytology
CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
Kerstin Schütze, Katharina Petry, Julia Hambach, Niklas Schuster, William Fumey, Levin Schriewer, Jana Larissa Röckendorf, Stephan Menzel, Birte Albrecht, Friedrich Haag et al. · 2018 · Frontiers in Immunology
Characterization of Chain Pairing Variants of Bispecific IgG Expressed in a Single Host Cell by High-Resolution Native and Denaturing Mass Spectrometry
Luis F. Schachner, Guanghui Han, Michael A. Dillon, Jianhui Zhou, Luke McCarty, Diego A. Ellerman, Yiyuan Yin, Christoph Spiess, Jennie Rebecca Lill, Paul J. Carter et al. · 2016 · Analytical Chemistry
Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies
Laurent Peyrin‐Biroulet, Stephen J. Demarest, Ajay Nirula · 2018 · Autoimmunity Reviews
A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer
Gururaj Shivange, Karol Urbanek, Piotr Przanowski, Justin S. A. Perry, James O. Jones, Robert Haggart, Christina Kostka, Tejal Patki, Edward B. Stelow, Yuliya I. Petrova et al. · 2018 · Cancer Cell
Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure features
Ameya Harmalkar, Roshan Rao, Yuxuan Richard Xie, Jonas Honer, Wibke Deisting, Jonas Anlahr, Anja Hoenig, Julia Czwikla, Eva Sienz-Widmann, Doris Rau et al. · 2023 · mAbs
Optimizing antibody expression: The nuts and bolts
B. Vijayalakshmi Ayyar, Sushrut Arora, Shiva Shankar Ravi · 2017 · Methods
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
Faroogh Marofi, Heshu Sulaiman Rahman, Lakshmi Prasanth Thangavelu, Aleksei Evgenievich Dorofeev, Favián Bayas-Morejón, Naghmeh Shirafkan, Navid Shomali, Max Stanley Chartrand, Mostafa Jarahian, Ghasem Vahedi et al. · 2021 · Stem Cell Research & Therapy
Summary of a workshop on preclinical and translational safety assessment of CD3 bispecifics
Cris Kamperschroer, Jacintha M. Shenton, Herve N. Lebrec, John K. Leighton, Paul A. Moore, Oliver Thomas · 2020 · Journal of Immunotoxicology
Recent Advances in LC–MS Based Characterization of Protein‐Based Bio‐Therapeutics—Mastering Analytical Challenges Posed by the Increasing Format Complexity
Graf, Tobias, Heinrich, Katrin, Grunert, Ingrid, Wegele, Harald, Haberger, Markus, Bulau, Patrick, Leiss, Michael · 2020 · Journal of Pharmaceutical and Biomedical Analysis
Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
Xiaotian Zhong, Aaron M. D’Antona · 2021 · Antibodies
Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors
Shou-Cheng Wu, Yu-Jen Chen, Hsiang-Ching Wang, Min-Yuan Chou, Teng‐Yuan Chang, Shyng‐Shiou F. Yuan, Chiao-Yun Chen, Ming‐Feng Hou, John T.-A. Hsu, Yun‐Ming Wang · 2015 · Theranostics
Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability
Takao Arimori, Yu Kitago, Masataka Umitsu, Yuki Fujii, Ryoko Asaki, Keiko Tamura‐Kawakami, Junichi Takagi · 2017 · Structure
Acute myeloid leukemia targets for bispecific antibodies
Sayed Shahabuddin Hoseini, Nai‐Kong V. Cheung · 2017 · Blood Cancer Journal
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
Thomas J. Van Blarcom, Kevin C. Lindquist, Zea Melton, Wai Ling Cheung‐Lee, Chris Wagstrom, Dan McDonough, Cendy A. Valle Oseguera, Sheng Ding, Andrea Rossi, Shobha Potluri et al. · 2017 · mAbs
T cell-redirecting bispecific antibodies in cancer immunotherapy: recent advances
Yu Lin, Jianhua Wang · 2019 · Journal of Cancer Research and Clinical Oncology
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
Ming Huei Cheng, Brian H. Santich, Hong Xu, Mahiuddin Ahmed, Morgan Huse, Nai‐Kong V. Cheung · 2016 · OncoImmunology
Building blocks for bispecific and trispecific antibodies
Xiufeng Wu, Stephen J. Demarest · 2018 · Methods
Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles
Natalia V. Gomez, Jonathan Lull, Xiaorui Yang, Yan Wang, Xin Zhang, Agatha Wieczorek, John Harrahy, Mike Pritchard, Diandra Martinez‐Cano, Michael Shearer et al. · 2020 · Biotechnology Progress
Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models
Karsten Michael Warwas, Marten Meyer, Márcia Gonçalves, Gerhard Moldenhauer, Nadja Bulbuc, Susanne Knabe, Claudia Luckner‐Minden, Claudia Ziegelmeier, Claus Peter Heußel, Inka Zörnig et al. · 2021 · Frontiers in Immunology
Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models
Aran F. Labrijn, Joyce I. Meesters, Matthew W. Bunce, Anthony A. Armstrong, Sandeep Somani, Tom Nesspor, Mark L. Chiu, Işıl Altıntaş, Sandra A.B.W. Verploegen, Janine Schuurman et al. · 2017 · Scientific Reports
Pharmacokinetics of Bispecific Antibody
Yang Chen, Yan Chun Xu · 2017 · Current Pharmacology Reports
Fabs-in-tandem immunoglobulin is a novel and versatile bispecific design for engaging multiple therapeutic targets
Shiyong Gong, Fang Ren, Danqing Wu, Xuan Wu, Chengbin Wu · 2017 · mAbs
Targeting ligand–receptor interactions for development of cancer therapeutics
Jun W. Kim, Jennifer R. Cochran · 2017 · Current Opinion in Chemical Biology
Antibody-Based Strategies to Prevent and Treat Influenza
Zachary H. Shriver, José Trevejo, Ram Sasisekharan · 2015 · Frontiers in Immunology
CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy
Bingyu Li, Lijun Xu, Chenyu Pi, Yanxin Yin, Kun Xie, Fei Tao, Renhao Li, Hua Gu, Jianmin Fang · 2017 · OncoImmunology
In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties
A André, Isa Moutinho, Joana Dias, Frederico Aires‐da‐Silva · 2022 · Frontiers in Microbiology
Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses
Julia Carina Frei, Elisabeth K. Nyakatura, Samantha E. Zak, Russell R. Bakken, Kartik Chandran, John M. Dye, Jonathan R. Lai · 2016 · Scientific Reports
Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability
Obinna C. Ubah, Magdalena J. Buschhaus, Laura Ferguson, Marina Kovaleva, John Steven, A.J. Porter, Caroline Jane Barelle · 2018 · Biochemical Society Transactions
Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells
Pritam Sinharoy, Aaron H. Aziz, Natalia I. Majewska, Sanjeev Ahuja, Michael W. Handlogten · 2020 · Scientific Reports
Exosome-based strategies for diagnosis and therapy of glioma cancer
Mohsen Karami Fath, Jalil Azami, Alireza Masoudi, Reza Mosaddeghi-Heris, Elnaz Rahmani, Fatemeh Alavi, Armina Alagheband Bahrami, Zahra Payandeh, Bahman Khalesi, Masoomeh Dadkhah et al. · 2022 · Cancer Cell International
Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry
Yiyuan Yin, Guanghui Han, Jianhui Zhou, Michael A. Dillon, Luke McCarty, Lou Gavino, Diego A. Ellerman, Christoph Spiess, Wendy N. Sandoval, Paul J. Carter · 2016 · mAbs
Erratum: Acute myeloid leukemia targets for bispecific antibodies
Sayed Shahabuddin Hoseini, Nai‐Kong V. Cheung · 2017 · Blood Cancer Journal
Purification of common light chain IgG-like bispecific antibodies using highly linear pH gradients
Beth Sharkey, Sarat Pudi, Ian Wallace Moyer, Lihui Zhong, Bianka Prinz, Hemanta Baruah, Heather Lynaugh, Sampath Kumar, Karl Dane Wittrup, Juergen H. Nett · 2016 · mAbs
Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
Yiyin Zhang, Chao Yang, He Cheng, Zhiyao Fan, Qiuyi Huang, Lu Yu, Kun Fan, Guopei Luo, Kaizhou Jin, Zhengshi Wang et al. · 2018 · Journal of Hematology & Oncology
The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation
Kip P. Conner, Siva Charan Devanaboyina, Veena A. Thomas, Dan A. Rock · 2020 · Pharmacology & Therapeutics
Development of bispecific antibodies in China: overview and prospects
Jing Zhang, Jizu Yi, Pengfei Zhou · 2020 · Antibody Therapeutics
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
Torleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, Stian Foss, Algirdas Grevys, Lene Støkken Høydahl, Øystein Kalsnes Jørstad, Tilman Schlothauer, Inger Sandlie, Morten C. Moe et al. · 2022 · Communications Biology
Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease
Yihan Xu, Weiming Zhu, Zhen Guo · 2022 · World Journal of Gastroenterology
Structural and Functional Characterization of a Hole–Hole Homodimer Variant in a “Knob-Into-Hole” Bispecific Antibody
Hui‐Min Zhang, Charlene Li, Ming Lei, Victor Lundin, Ho‐Young Lee, Milady R. Niñonuevo, Kevin Lin, Guanghui Han, Wendy N. Sandoval, Dongsheng Lei et al. · 2017 · Analytical Chemistry
MAPPs for the identification of immunogenic hotspots of biotherapeutics; an overview of the technology and its application to the biopharmaceutical arena
Valerie E. Quarmby, Qui T. Phung, Jennie Rebecca Lill · 2018 · Expert Review of Proteomics
Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
Yan Yang, Zheng Yang, Yun Yang · 2021 · Frontiers in Immunology
Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies
Josée Golay, Sylvie Choblet, Justyna Iwaszkiewicz, Pierre Cérutti, Annick Ozil, Séverine Loisel, Martine Pugnière, Greta Ubiali, Vincent Zoete, Olivier Alain Michielin et al. · 2016 · The Journal of Immunology
Bispecific T-cell engagers for the recruitment of T cells in solid tumors: a literature review
Laura Dewaele, Ricardo A. Fernandes · 2024 · Immunotherapy Advances
T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies
Paweł Cech, Katarzyna Skórka, Laura Dziki, Krzysztof Giannopoulos · 2024 · Cancers
Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
Kristina Ellwanger, Uwe Reusch, Ivica Fucek, Stefan H.J. Knackmuss, Michael Weichel, Thorsten Gantke, Vera Molkenthin, Eugene A. Zhukovsky, Michael Tesar, Martin Treder · 2017 · Frontiers in Oncology
Fcab-HER2 Interaction: a Ménage à Trois. Lessons from X-Ray and Solution Studies
Elisabeth Laurent, Anne-Sophie Humm, Kathrin Göritzer, Georg Mlynek, Martin Gerald Puchinger, Christoph Hasenhindl, Florian Rüker, Michael W. Traxlmayr, Kristina Djinović‐Carugo, Christian Obinger · 2017 · Structure
Multivalent protein-drug conjugates – An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells
Natalia Porębska, Krzysztof Ciura, Aleksandra Chorążewska, Małgorzata Zakrzewska, Jacek Otlewski, Łukasz Opaliński · 2023 · Biotechnology Advances
Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry
Wolfgang M. Schäfer, Hans Rainer Völger, Stefan H. Lorenz, Sabine Imhof-Jung, Jörg T. Regula, Christian Klein, Michael Mølhøj · 2015 · mAbs
A Novel Affibody-Auristatin E Conjugate With a Potent and Selective Activity Against HER2+ Cell Lines
Alicja M. Sochaj-Gregorczyk, Anna Maria Serwotka-Suszczak, Jacek Otlewski · 2016 · Journal of Immunotherapy
T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
Daisuke Kamakura, Ryutaro Asano, Masahiro Yasunaga · 2021 · Pharmaceuticals
Characterization and analysis of scFv-IgG bispecific antibody size variants
Mingyan Cao, Chunlei Wang, Wai Keen Chung, Dana Motabar, Jihong Wang, Elizabeth A. Christian, Shi‐Hua Lin, Alan K. Hunter, Xiangyang Wang, Dengfeng Liu · 2018 · mAbs
Microfluidic methods for cell separation and subsequent analysis
Tianyou Chen, Chunxia Huang, Yanran Wang, Jing Wu · 2021 · Chinese Chemical Letters
An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform‐Like Purification Process
Cassia Andrade, Lindsay Arnold, Dana Motabar, Matthew T. Aspelund, Alison Tang, Alan K. Hunter, Wai Keen Chung · 2018 · Biotechnology Progress
Visualisation of intracellular production bottlenecks in suspension-adapted CHO cells producing complex biopharmaceuticals using fluorescence microscopy
Sven Mathias, Simon Fischer, René Handrick, Jürgen Fieder, Patrick Schulz, Harald Bradl, Ingo H. Gorr, Martin Gamer, Kerstin Otte · 2018 · Journal of Biotechnology
A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity
Sally Yu Shi, Ya‐Wen Lu, Zhi Liu, Jennitte L. Stevens, Christopher M. Murawsky, Vicki Wilson, Zhonghua Hu, William G. Richards, Mark Leo Michaels, Jun Zhang et al. · 2018 · Journal of Biological Chemistry
Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer
Huimin Liu, Lele Ma, Junzhi Lin, Bo Cao, Duan Qu, Chuanhong Luo, Wei Huang, Li Han, Hong Xu, Zhenfeng Wu et al. · 2020 · Pharmacological Research
Tailoring translational strength using Kozak sequence variants improves bispecific antibody assembly and reduces product‐related impurities in CHO cells
Noelia Blanco, Ambrose J. Williams, Danming Tang, Dejin Zhan, Shahram Misaghi, Robert F. Kelley, Laura C. Simmons · 2020 · Biotechnology and Bioengineering
Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
Ames C. Register, Somayeh Samadzadeh Tarighat, Ho‐Young Lee · 2021 · International Journal of Molecular Sciences
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
Kirit Singh, Kelly M. Hotchkiss, Aditya A Mohan, Jessica L. Reedy, John Howard Sampson, Mustafa Khasraw · 2021 · Journal for ImmunoTherapy of Cancer
Current Mass Spectrometric Tools for the Bioanalyses of Therapeutic Monoclonal Antibodies and Antibody-Drug Conjugates
Kenichiro Todoroki, Tomohiro Yamada, Hajime Mizuno, Toshimasa Toyo’oka · 2018 · Analytical Sciences
Modulating binding affinity, specificity, and configurations by multivalent interactions
Yunxin Deng, Artem K. Efremov, Jie Yan · 2022 · Biophysical Journal
Synthetic Modular Antibody Construction by Using the SpyTag/SpyCatcher Protein‐Ligase System
Md. Kausar Alam, Carolina Gonzalez, Wayne Hill, Ayman El‐Sayed, Humphrey Fonge, Kris Barreto, Clarence Ronald Geyer · 2017 · ChemBioChem
Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidity
Andrew D. Tustian, Linus Laurin, Henrik R. Ihre, Travis Tran, Robert Stairs, Hanne Bak · 2018 · Biotechnology Progress
Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeutics
Katy L. Everett, Matthew Kraman, Francisca Wollerton, Carlo Zimarino, Katarzyna Kmiecik, Miguel A. Gaspar, Sarka Pechouckova, Natalie L. Allen, Jacqueline F. Doody, Mihriban Tuna · 2018 · Methods
Antibody and antibody derivatives as cancer therapeutics
Keith J. Arlotta, Shawn C. Owen · 2019 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
The manufacturing considerations of bispecific antibodies
Dennis J. Underwood, Jeffrey Bettencourt, Zahra Jawad · 2022 · Expert Opinion on Biological Therapy
LC–MS Challenges in Characterizing and Quantifying Monoclonal Antibodies (mAb) and Antibody-Drug Conjugates (ADC) in Biological Samples
Cong Wei, Dian Su, Jian Wang, Wenying Jian, Donglu Zhang · 2018 · Current Pharmacology Reports
Variable heavy–variable light domain and Fab-arm CrossMabs with charged residue exchanges to enforce correct light chain assembly
Jörg T. Regula, Sabine Imhof-Jung, Michael Mølhøj, Joerg Benz, A. Ehler, Alexander Bujotzek, Wolfgang M. Schäfer, Christian Klein · 2018 · Protein Engineering Design and Selection
Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies
Karen Froning, Andrew Leaver‐Fay, Xiufeng Wu, S. Phan, Ling Gao, F. Huang, Anna Pustilnik, Michael Bacica, Kevin Houlihan, Qing Chai et al. · 2017 · Protein Science
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
Vitaly V. Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Anatolyevich Rizvanov et al. · 2024 · Antibodies
Integrating Computational Design and Experimental Approaches for Next-Generation Biologics
Son, Ahrum, Park, Jongham, Kim, Woojin, Lee, Wonseok, Yoon, Yoonki, Ji, Jaeho, Kim, Hyunsoo · 2024 · Biomolecules
CHO Cell Line Development and Engineering via Site-specific Integration: Challenges and Opportunities
Sung Wook Shin, Jae Seong Lee · 2020 · Biotechnology and Bioprocess Engineering